Table 1 Demographic, clinical and food intake data of children and adolescents with polyarticular and systemic JIA subtypes
Variables | N = 62 | |
|---|---|---|
Female N (%) | 46 (74.2) | |
Age, Mean ± SD | 7.7 ± 4.3 | |
Socio-economic classification N(%) | ||
A | 5 (8.0) | |
B/C | 54 (87.1) | |
D/E | 3 (4.8) | |
Pubertal stage N(%) | ||
Pubertal | 26 (41.9) | |
Pre/Pos-pubertal | 36 (58.1) | |
Disease subtype N(%) | ||
JIA RF+ | 10 (16.1) | |
JIA RF- | 39 (62.9) | |
Systemic | 13 (21.0) | |
Disease follow up time (years), Mean ± SD | 5.0 ± 3.4 | |
Disease activity N(%) | ||
Active | 21 (33.9) | |
Inactive | 5 (8.0) | |
Remission on medication | 29 (46.8) | |
Remission off medication | 7 (11.3) | |
Biological DMARDs N(%) | 16 (25.8) | |
Synthetic DMARDs N(%) | 40 (64.5) | |
Corticosteroids N(%) | 6 (9.7) | |
Cumulative dosis of corticosteroids (mg) | 2620 | 1762.5–7483.7 |
CHAQ altered N(%) | 17(27.4) | |
CHAQ, Mean ± SD | 1.2 (0.8) | |